Cart
sales@molnova.com
CCR10 antagonist 1
CAS No. 1191031-97-6
CCR10 antagonist 1( —— )
Catalog No. M10657 CAS No. 1191031-97-6
CCR10 antagonist 1 is a potent, selective CCR10 antagonist with IC50 of 690 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCCR10 antagonist 1
-
NoteResearch use only, not for human use.
-
Brief DescriptionCCR10 antagonist 1 is a potent, selective CCR10 antagonist with IC50 of 690 nM.
-
DescriptionCCR10 antagonist 1 is a potent, selective CCR10 antagonist with IC50 of 690 nM; demonstrates functional CCR1 antagonism by inhibiting the CCL27 dependent chemotaxis of Ba/F3 cells stably transfected with human CCR10 with an IC50 of 53 nM, exhibits no antagonism of murine CCL27 dependent Ca2+ flux in CHO-K cells stably transfected with murine CCR10 at 20 uM.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetChemokine Receptor
-
RecptorChemokine Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1191031-97-6
-
Formula Weight519.398
-
Molecular FormulaC19H24Cl2N6O5S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name4-amino-3,5-dichloro-N-(1-(4-methylpiperidin-1-yl)-4-(2-nitro-1H-imidazol-1-yl)-1-oxobutan-2-yl)benzenesulfonamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Abeywardane A, et al. Bioorg Med Chem Lett. 2016 Nov 1;26(21):5277-5283.
molnova catalog
related products
-
CCR10 antagonist 1
CCR10 antagonist 1 is a potent, selective CCR10 antagonist with IC50 of 690 nM.
-
CCR6 inhibitor 35
CCR6 inhibitor 35 is a potent and selective CCR6 inhibitor with IC50 of 6.0 nM (hCCR6).
-
CX 4338
CX 4338 (CX4338, CX-4338)?is a potent, selective CXCR2 inhibitor that selectively inhibits CXCR2-mediated recruitment of β-arrestin-2 with IC50 of 6.3 uM.
